BDBM98591 3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methylamino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]sulfamoylmethyl]benzoic acid::US8476306, 6.17

SMILES NC(=N)c1ccc(CNC(=O)[C@H](CO)NC(=O)[C@@H](CO)NS(=O)(=O)Cc2cccc(c2)C(O)=O)cc1

InChI Key InChIKey=BFBUYZVPTHCXCJ-ZWKOTPCHSA-N

Data  4 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 98591   

TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98591(3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  58nM ΔG°:  -9.83kcal/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98591(3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  75nM ΔG°:  -9.68kcal/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98591(3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  4.20E+3nM ΔG°:  -7.31kcal/moleT: 2°CAssay Description:Inhibition constant of the compound against PlasminMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProthrombin(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98591(3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  2.00E+5nM ΔG°:  -5.03kcal/moleT: 2°CAssay Description:Inhibition constant of the compound against ThrombinMore data for this Ligand-Target Pair
In DepthDetails US Patent